Tuesday, January 26, 2021
Speech and Exercise
Tue. 26 Jan, 2021 4:45 pm - 6:15 pm
Speech and Exercise with Gilda Dimayuga, M.S., CCC-SLP, CBIS and Fereshteh Golchin, PTA
Mesenchymal Stem Cell Therapy for Idiopathic Parkinson's Disease: a Phase II Trial
Tue. 26 Jan, 2021 6:00 pm - 7:00 pm
Community Partners Presents:
Presented by Mya Schiess, MD and Vanessa K. Thyne, MS
Learn more about this local phase II clinical trail which has been approved by the FDA to select the safest and most effective number of repeat doses of allogeneic bone marrow-derived mesenchymal stem cell infusions to slow the progression of PD.